Van ECK Associates Corp Acquires Shares of 38,397 The Cooper Companies, Inc. $COO

Van ECK Associates Corp bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 38,397 shares of the medical device company’s stock, valued at approximately $2,753,000.

Several other large investors have also made changes to their positions in COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after purchasing an additional 7,363 shares during the last quarter. First Trust Advisors LP grew its stake in Cooper Companies by 115.8% during the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after buying an additional 73,165 shares during the last quarter. Cresset Asset Management LLC acquired a new stake in shares of Cooper Companies during the second quarter worth approximately $291,000. Cerity Partners LLC increased its holdings in shares of Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after buying an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. raised its stake in shares of Cooper Companies by 2.8% in the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after acquiring an additional 973 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on COO. Weiss Ratings downgraded Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research report on Wednesday, May 27th. Needham & Company LLC decreased their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a report on Friday, June 5th. Wells Fargo & Company restated a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Finally, JPMorgan Chase & Co. cut their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $81.64.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $70.64 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The firm has a market cap of $13.78 billion, a P/E ratio of 59.86, a P/E/G ratio of 1.82 and a beta of 0.82. The firm has a 50 day simple moving average of $72.74 and a 200 day simple moving average of $70.46. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the previous year, the company posted $0.96 EPS. Cooper Companies’s revenue was up 7.9% on a year-over-year basis. Sell-side analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.